DC Business DC
Gaithersburg biotech gets green light for superbug therapy, explores COVID-19 vaccine production
Adaptive Phage Therapeutics can take its therapy for superbugs to human trials.
Adaptive Phage Therapeutics can take its therapy for superbugs to human trials.